CN1278269A - 哌嗪-环糊精复合体 - Google Patents
哌嗪-环糊精复合体 Download PDFInfo
- Publication number
- CN1278269A CN1278269A CN98810777A CN98810777A CN1278269A CN 1278269 A CN1278269 A CN 1278269A CN 98810777 A CN98810777 A CN 98810777A CN 98810777 A CN98810777 A CN 98810777A CN 1278269 A CN1278269 A CN 1278269A
- Authority
- CN
- China
- Prior art keywords
- group
- alkyl
- nitrogen
- atoms
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nanotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP305889/1997 | 1997-11-07 | ||
JP30588997 | 1997-11-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1278269A true CN1278269A (zh) | 2000-12-27 |
Family
ID=17950538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN98810777A Pending CN1278269A (zh) | 1997-11-07 | 1998-10-29 | 哌嗪-环糊精复合体 |
Country Status (9)
Country | Link |
---|---|
US (1) | US6596706B1 (no) |
EP (1) | EP1029872A4 (no) |
KR (1) | KR20010031520A (no) |
CN (1) | CN1278269A (no) |
AU (1) | AU9650398A (no) |
CA (1) | CA2306465A1 (no) |
NO (1) | NO20002159L (no) |
RU (1) | RU2216549C2 (no) |
WO (1) | WO1999024475A1 (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2778413B1 (fr) * | 1998-05-07 | 2000-08-04 | Immunotech Sa | Nouveaux reactifs et methode de lyse des erythrocytes |
WO2002055076A1 (fr) * | 2001-01-04 | 2002-07-18 | Daiichi Pharmaceutical Co., Ltd. | Preparation pharmaceutique contenant de la cyclodextrine |
US6982256B2 (en) | 2001-09-07 | 2006-01-03 | Boehringer Ingelheim Pharma Kg | Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration |
PT1558595E (pt) * | 2002-10-23 | 2010-01-15 | Janssen Pharmaceutica Nv | Piperazinil e diazepanil benzamidas e benzotioamidas |
US7257377B2 (en) * | 2003-02-18 | 2007-08-14 | Qualcomm, Incorporated | Systems and methods for improving channel estimation |
WO2007023882A1 (ja) | 2005-08-26 | 2007-03-01 | Shionogi & Co., Ltd. | Pparアゴニスト活性を有する誘導体 |
WO2007035425A2 (en) | 2005-09-16 | 2007-03-29 | Janssen Pharmaceutica N.V. | Cyclopropyl amines as modulators of the histamine h3 receptor |
EP2352501B1 (en) * | 2008-11-03 | 2014-01-01 | ChemoCentryx, Inc. | Compounds for use in the treatment of osteoporosis |
WO2020138421A1 (ja) * | 2018-12-27 | 2020-07-02 | 国立大学法人熊本大学 | 脳移行性リガンド及び薬物担体 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3346123A1 (de) | 1983-12-21 | 1985-06-27 | Janssen Pharmaceutica, N.V., Beerse | Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung |
NZ224497A (en) * | 1987-05-18 | 1990-04-26 | Janssen Pharmaceutica Nv | Pharmaceutical composition comprising flunarizine |
US5376645A (en) * | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
CA2061891A1 (en) * | 1991-03-08 | 1992-09-09 | Robert F. Van Ginckel | Flunarizine containing anti-neoplastic compositions |
FR2693722B1 (fr) | 1992-07-16 | 1994-10-14 | Meram Lab | Dérivés de la N-cycloalkylpipérazine, procédé d'obtention et compositions pharmaceutiques les contenant. |
JPH0640890A (ja) | 1992-07-24 | 1994-02-15 | Nippon Oil & Fats Co Ltd | 徐放性製剤 |
JPH0813257B2 (ja) | 1992-11-25 | 1996-02-14 | 日成興産株式会社 | 痩身用食品 |
RU2124511C1 (ru) | 1993-05-14 | 1999-01-10 | Фармасьютикал Ко., Лтд | Производные пиперазина |
-
1998
- 1998-10-29 WO PCT/JP1998/004896 patent/WO1999024475A1/ja not_active Application Discontinuation
- 1998-10-29 CN CN98810777A patent/CN1278269A/zh active Pending
- 1998-10-29 US US09/530,592 patent/US6596706B1/en not_active Expired - Fee Related
- 1998-10-29 CA CA002306465A patent/CA2306465A1/en not_active Abandoned
- 1998-10-29 KR KR1020007004561A patent/KR20010031520A/ko not_active Application Discontinuation
- 1998-10-29 AU AU96503/98A patent/AU9650398A/en not_active Abandoned
- 1998-10-29 RU RU2000114807/04A patent/RU2216549C2/ru not_active IP Right Cessation
- 1998-10-29 EP EP98950441A patent/EP1029872A4/en not_active Withdrawn
-
2000
- 2000-04-27 NO NO20002159A patent/NO20002159L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20010031520A (ko) | 2001-04-16 |
AU9650398A (en) | 1999-05-31 |
NO20002159D0 (no) | 2000-04-27 |
EP1029872A1 (en) | 2000-08-23 |
EP1029872A4 (en) | 2001-05-02 |
RU2216549C2 (ru) | 2003-11-20 |
NO20002159L (no) | 2000-04-27 |
US6596706B1 (en) | 2003-07-22 |
CA2306465A1 (en) | 1999-05-20 |
WO1999024475A1 (fr) | 1999-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1184208C (zh) | 取代的苯并咪唑及其制备和用途 | |
CN1151127C (zh) | 吲哚衍生物及其用于治疗恶性肿瘤和其它基于病理细胞增生的疾病的用途 | |
CN1222511C (zh) | 作为5-羟色胺-6配体的1-芳基-或1-烷基磺酰基-杂环基吲哚 | |
CN1165535C (zh) | 抑制胃酸分泌的咪唑并吡啶衍生物 | |
CN1247568C (zh) | 可作为香草素受体拮抗剂用于治疗疼痛的脲类化合物 | |
CN1117077C (zh) | 用作nos抑制剂的6-苯基吡啶基-2-胺衍生物 | |
CN100338036C (zh) | 对激酶及细胞周期蛋白复合物具有抑制作用的取代的吲哚满酮 | |
CN1152866C (zh) | 苯并咪唑,其制法及其作为药物组合物的用途 | |
CN1178911C (zh) | 吡咯烷与哌啶衍生物和它们用于治疗神经变性疾病的用途 | |
CN1211385C (zh) | 双环咪唑-5-基胺衍生物 | |
CN1087904A (zh) | 羧酸衍生物,含有这些化合物的药物组合物以及其制备方法 | |
CN1100535C (zh) | 用于治疗呕吐的药剂 | |
CN1376156A (zh) | 苯并二氮杂䓬衍生物、其制备和用途 | |
CN101044135A (zh) | 喹啉衍生物 | |
CN1633294A (zh) | 2,4,5-三取代噻唑衍生物和它们的抗炎活性 | |
CN1960727A (zh) | 用作组胺-3受体的配体的萘衍生物 | |
CN1656082A (zh) | 蛋白激酶抑制剂 | |
CN1374962A (zh) | 8-苯基-6,9-二氢-[1,2,4]***并[3,4-i]嘌呤-5-酮衍生物 | |
CN1671696A (zh) | 激酶抑制剂 | |
CN87100928A (zh) | 哌啶衍生物及其药物组合物 | |
CN1268133A (zh) | 含有稠合环取代基的作为nos抑制剂的2-氨基吡啶 | |
CN1059908A (zh) | 嘧啶衍生物及其药物 | |
CN1250542C (zh) | 具有抗肿瘤活性的2-(1h-吲哚-3-基)-2-氧代-乙酰胺 | |
CN1278269A (zh) | 哌嗪-环糊精复合体 | |
CN1320123A (zh) | 二取代马来酰亚胺化合物及其医药用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1030001 Country of ref document: HK |